Search

everythinglearnresearchcommunity

for

Search:↓

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Betamethasone oral mini-pulse therapy is safe and effective for treating extensive alopecia areata.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Lasers and light therapies are effective in promoting hair regrowth for different types of hair loss.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

Using thigh skin, doctors successfully rebuilt a woman's scalp after removing a large tumor, with no tumor return after 8 months.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

A single hair transplant treatment was effective for a mild scalp condition.

PRP and IT are equally effective for treating localized alopecia areata, but PRP causes more pain and bleeding.

PUVA treatment is effective and safe for alopecia areata.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

Autoimmune reactions may cause both alopecia areata and HAM.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Combining cytostatic and steroid drugs effectively treats systemic lupus erythematosus.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Early and accurate diagnosis of primary vitreoretinal lymphoma is crucial to prevent serious complications.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Microneedling with PRP is a safe and effective way to treat chronic alopecia areata, improving hair regrowth with minimal side effects.

Stopping azathioprine led to full hair regrowth and recovery in 2.5 months.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

Surgical repigmentation can permanently restore color to white hair in vitiligo patients.

Hair loss from cancer treatment is a major emotional burden for patients because it affects their appearance and constantly reminds them of their illness.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Two patients with stubborn hair loss grew hair after PDRN injections.